BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2258189)

  • 1. Antigen presentation in MHC class II transgenic mice: stimulation versus tolerization.
    Lo D; Burkly LC; Flavell RA; Palmiter RD; Brinster RL
    Immunol Rev; 1990 Oct; 117():121-34. PubMed ID: 2258189
    [No Abstract]   [Full Text] [Related]  

  • 2. A new look at MHC and autoimmune disease.
    Ridgway WM; Fassò M; Fathman CG
    Science; 1999 Apr; 284(5415):749, 751. PubMed ID: 10336398
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerance in transgenic mice expressing major histocompatibility molecules extrathymically on pancreatic cells.
    Burkly LC; Lo D; Flavell RA
    Science; 1990 Jun; 248(4961):1364-8. PubMed ID: 1694042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses.
    Dongre AR; Kovats S; deRoos P; McCormack AL; Nakagawa T; Paharkova-Vatchkova V; Eng J; Caldwell H; Yates JR; Rudensky AY
    Eur J Immunol; 2001 May; 31(5):1485-94. PubMed ID: 11465105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class II MHC antigen processing in immune tolerance and inflammation.
    Jurewicz MM; Stern LJ
    Immunogenetics; 2019 Mar; 71(3):171-187. PubMed ID: 30421030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A minimal level of MHC class II expression is sufficient to abrogate autoreactivity.
    de Bont ES; Reilly CR; Lo D; Glimcher LH; Laufer TM
    Int Immunol; 1999 Aug; 11(8):1295-306. PubMed ID: 10421787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-presenting cells in the thymus that can negatively select MHC class II-restricted T cells recognizing a circulating self antigen.
    Volkmann A; Zal T; Stockinger B
    J Immunol; 1997 Jan; 158(2):693-706. PubMed ID: 8992985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell reactivity to MHC molecules: immunity versus tolerance.
    Sprent J; Gao EK; Webb SR
    Science; 1990 Jun; 248(4961):1357-63. PubMed ID: 1694041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How the immune system learns about self.
    von Boehmer H; Kisielow P
    Sci Am; 1991 Oct; 265(4):74-81. PubMed ID: 1836069
    [No Abstract]   [Full Text] [Related]  

  • 11. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
    Guéry JC; Sette A; Appella E; Adorini L
    J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compartmentalization of MHC class II gene expression in transgenic mice.
    van Ewijk W; Ron Y; Monaco J; Kappler J; Marrack P; Le Meur M; Gerlinger P; Durand B; Benoist C; Mathis D
    Cell; 1988 May; 53(3):357-70. PubMed ID: 3259162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ii41 isoform of invariant chain mediates both positive and negative selection events in T-cell receptor transgenic mice.
    Wright RJ; Bikoff EK; Stockinger B
    Immunology; 1998 Nov; 95(3):309-13. PubMed ID: 9824491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
    Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
    J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen.
    Zal T; Volkmann A; Stockinger B
    J Exp Med; 1994 Dec; 180(6):2089-99. PubMed ID: 7964486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothesis for autoantigen presentation and T cell activation.
    Mircheff AK; Gierow JP; Wood RL; Akashi RH; Hofman FM
    Adv Exp Med Biol; 1994; 350():651-4. PubMed ID: 8030550
    [No Abstract]   [Full Text] [Related]  

  • 18. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic tuning of T cell reactivity by self-peptide-major histocompatibility complex ligands.
    Wong P; Barton GM; Forbush KA; Rudensky AY
    J Exp Med; 2001 May; 193(10):1179-87. PubMed ID: 11369789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
    Agrawal B; Manickasundari M; Fraga E; Singh B
    J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.